Literature DB >> 29252913

PARACENTRAL ACUTE MIDDLE MACULOPATHY IN PREGNANCY.

Xuejing Chen1,2, Shilpa J Desai1,2, Caroline R Baumal1.   

Abstract

PURPOSE: To describe a case of paracentral acute middle maculopathy (PAMM) during the first trimester of pregnancy without other ocular or systemic comorbidities.
METHODS: Case report.
RESULTS: A 31-year-old woman in her first trimester of pregnancy presented with a paracentral scotoma in the absence of other retinal pathology or systemic associations. Optical coherence tomography showed a classic acute PAMM lesion, and optical coherence tomography angiography showed preservation of vascular flow in the area of the PAMM lesion 1 week after symptom onset. Subsequent workup for underlying systemic disease that can affect the retinal vasculature was negative.
CONCLUSION: Paracentral acute middle maculopathy lesions have been described in eyes with retinal vascular disease and in people with systemic vascular diseases or events. This is the first described case of a PAMM lesion in the absence of associated factors other than an uncomplicated pregnancy.

Entities:  

Mesh:

Year:  2020        PMID: 29252913     DOI: 10.1097/ICB.0000000000000679

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  3 in total

1.  Transient vision loss associated with paracentral acute middle maculopathy detected on multi-modal imaging.

Authors:  Jesse D Sengillo; Lily Zhang; Jayanth Sridhar; Harry W Flynn; Stephen G Schwartz
Journal:  Am J Ophthalmol Case Rep       Date:  2021-08-26

Review 2.  Retinal vascular occlusion in pregnancy: three case reports and a review of the literature.

Authors:  L Jürgens; R Yaici; C M Schnitzler; A K Fleitmann; M Roth; K Schröder; R Guthoff
Journal:  J Med Case Rep       Date:  2022-04-21

3.  Paracentral Acute Middle Maculopathy and Central Retinal Venous Occlusion following Electrical Injury.

Authors:  Sahel Khazaei; Mehrdad Motamed Shariati; Naser Shoeibi; Mohammad Arjmand; Seyedeh Maryam Hosseini
Journal:  Case Rep Ophthalmol Med       Date:  2022-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.